The prognosis for patients with newly diagnosed glioblastoma receiving bevacizumab combination therapy: a meta-analysis
KL Liao, S Huang, YP Wu - OncoTargets and therapy, 2018 - Taylor & Francis
… were not possible in this meta-analysis. In a previous meta-analysis, BEV therapy was
not … in the included trials is limited, we did not perform the analysis of AEs in this meta-analysis. …
not … in the included trials is limited, we did not perform the analysis of AEs in this meta-analysis. …
The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysis
… were to: [1] define the type of bevacizumab combinations used in advanced EOC; [2] …
bevacizumab combinations in advanced and recurrent setting; and [3] assess safety of bevacizumab…
bevacizumab combinations in advanced and recurrent setting; and [3] assess safety of bevacizumab…
… of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta …
TEA Botrel, LGO Clark, L Paladini, OAC Clark - BMC cancer, 2016 - Springer
… with meta-analysis evaluating the use of bevacizumab combined with … This meta-analysis
included 7 studies and raised questions … plus bevacizumab combination in first-line therapy. …
included 7 studies and raised questions … plus bevacizumab combination in first-line therapy. …
The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors-a meta-analysis and systematic review
L Amit, I Ben-Aharon, L Vidal, L Leibovici, S Stemmer - PloS one, 2013 - journals.plos.org
… The combination of Taxanes or Capecitabine with Bevacizumab until … of Bevacizumab in
solid tumors and the conflicting overall survival results, we aimed to perform a meta-analysis of …
solid tumors and the conflicting overall survival results, we aimed to perform a meta-analysis of …
Bevacizumab combined with chemotherapy improves survival for patients with metastatic colorectal cancer: evidence from meta analysis
… The findings of this meta analysis confirm the benefit of adding bevacizumab to chemotherapy
in terms of … This suggests the need for further research of interaction of bevacizumab with …
in terms of … This suggests the need for further research of interaction of bevacizumab with …
Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis
V Ranpura, S Hapani, S Wu - Jama, 2011 - jamanetwork.com
… Context Fatal adverse events (FAEs) have been reported in cancer patients treated with
the widely used angiogenesis inhibitor bevacizumab in combination with chemotherapy. …
the widely used angiogenesis inhibitor bevacizumab in combination with chemotherapy. …
[HTML][HTML] Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials
SB Yang, KD Gao, T Jiang, SJ Cheng, WB Li - Oncotarget, 2017 - ncbi.nlm.nih.gov
… to explore the efficacy of combination therapy. In this meta-analysis, we aimed to collect …
to assess the efficacy and safety of bevacizumab combined with chemotherapy versus single-…
to assess the efficacy and safety of bevacizumab combined with chemotherapy versus single-…
[HTML][HTML] Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials
YS Wu, L Shui, D Shen, X Chen - Oncotarget, 2017 - ncbi.nlm.nih.gov
… The results of three trials (OCEANS, AURELIA and GOG-213) in this meta-analysis demonstrate
that bevacizumab combined with chemotherapy is a great treatment option for recurrent …
that bevacizumab combined with chemotherapy is a great treatment option for recurrent …
Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
R Xu, C Xu, C Liu, C Cui, J Zhu - OncoTargets and therapy, 2018 - Taylor & Francis
… present meta-analysis was to evaluate the clinical value of bevacizumab-based combination
… This meta-analysis shows that the addition of IFL to bevacizumab better benefits PFS and …
… This meta-analysis shows that the addition of IFL to bevacizumab better benefits PFS and …
Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
M Miyashita, M Hattori, T Takano, T Toyama, H Iwata - Breast Cancer, 2020 - Springer
… our meta-analysis indicates that compared with chemotherapy alone, bevacizumab combined
… However, bevacizumab administration was associated with therapy discontinuation due to …
… However, bevacizumab administration was associated with therapy discontinuation due to …
相关搜索
- meta analysis bevacizumab in cancer patients
- meta analysis bevacizumab treatment
- meta analysis systematic review
- meta analysis metastatic colorectal cancer
- meta analysis randomized controlled trials
- meta analysis breast cancer
- meta analysis role of bevacizumab
- bevacizumab combination therapy
- meta analysis angiogenesis inhibitor bevacizumab
- meta analysis standard chemotherapy
- first line bevacizumab in combination
- meta analysis ovarian cancer
- meta analysis efficacy and safety
- meta analysis addition of bevacizumab
- meta analysis first line chemotherapy
- meta analysis efficacy of bevacizumab